SABCS 2024 | COMET: early oncologic outcomes in active monitoring or surgery in DCIS

Puneet Singh • 13 Dec 2024

SABCS 2024

Breast Cancer

COMET

Puneet Singh, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses findings from the COMET trial (NCT02926911), a randomized study comparing active monitoring (AM) to guideline concordant care (GCC) in patients with low-risk ductal carcinoma in situ (DCIS). The results aim to assess the safety of AM as an alternative to surgery and inform future management strategies for patients with low-risk DCIS. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.